Tarsus Pharmaceuticals Inc (TARS) Insider Trading
- $8,575,268.80
- $27,654,139.47
- March 18, 2024
- Bobak R Azamian
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 23, 2023 | CEO | 4,856 | $15.45 | Sell | $75,025.20 | |
Jan. 20, 2023 | CEO | 240 | $15.00 | Sell | $3,600.00 | |
Jan. 19, 2023 | CFO | 5,000 | $14.56 | Sell | $72,800.00 | |
Jan. 18, 2023 | CEO | 8,000 | $14.56 | Sell | $116,480.00 | |
Jan. 11, 2023 | CEO | 3,904 | $15.11 | Sell | $58,989.44 | |
Jan. 9, 2023 | CEO | 729 | $15.15 | Sell | $11,044.35 | |
Dec. 21, 2022 | CEO | 8,000 | $14.57 | Sell | $116,560.00 | |
Dec. 16, 2022 | CEO | 535 | $15.01 | Sell | $8,030.35 | |
Dec. 15, 2022 | CFO | 5,000 | $14.64 | Sell | $73,200.00 | |
Dec. 14, 2022 | CEO | 6,420 | $15.08 | Sell | $96,813.60 | |
Dec. 2, 2022 | Insider | 1,154 | $16.90 | Sell | $19,502.60 | |
Nov. 30, 2022 | General Counsel | 1,183 | $16.50 | Sell | $19,519.50 | |
Nov. 30, 2022 | Insider | 1,182 | $16.50 | Sell | $19,503.00 | |
Nov. 15, 2022 | Insider | 6,857 | $17.72 | Sell | $121,506.04 | |
Oct. 19, 2022 | CEO | 8,000 | $16.92 | Sell | $135,360.00 | |
Oct. 12, 2022 | CEO | 9,000 | $15.91 | Sell | $143,190.00 | |
Sept. 21, 2022 | CEO | 8,000 | $16.31 | Sell | $130,480.00 | |
Sept. 15, 2022 | CFO | 5,000 | $16.03 | Sell | $80,150.00 | |
Sept. 14, 2022 | CEO | 9,000 | $16.01 | Sell | $144,090.00 | |
Sept. 14, 2022 | Director | 18,400 | $16.12 | Buy | $296,608.00 | |
Aug. 18, 2022 | CFO | 5,000 | $16.30 | Sell | $81,500.00 | |
Aug. 17, 2022 | CEO | 8,000 | $16.59 | Sell | $132,720.00 | |
May 5, 2022 | Director | 100,000 | $13.50 | Buy | $1,350,000.00 | |
May 4, 2022 | Major Shareholder | 19,738 | $12.67 | Sell | $250,080.46 | |
May 2, 2022 | Major Shareholder | 41,800 | $15.19 | Sell | $634,942.00 | |
Dec. 1, 2021 | Director | 5,833 | $24.68 | Sell | $143,958.44 | |
Nov. 8, 2021 | Insider | 1,889 | $28.11 | Sell | $53,099.79 | |
Nov. 4, 2021 | Insider | 100 | $28.03 | Sell | $2,803.00 | |
Nov. 2, 2021 | Insider | 6,000 | $26.78 | Sell | $160,680.00 | |
Nov. 1, 2021 | Director | 5,833 | $27.82 | Sell | $162,274.06 | |
Oct. 12, 2021 | CEO | 5,531 | $26.30 | Sell | $145,465.30 | |
Oct. 12, 2021 | Director | 5,633 | $26.27 | Sell | $147,978.91 | |
Oct. 8, 2021 | Director | 200 | $25.03 | Sell | $5,006.00 | |
Oct. 8, 2021 | CEO | 302 | $25.02 | Sell | $7,556.04 | |
Sept. 10, 2021 | Insider | 2,593 | $22.15 | Sell | $57,434.95 | |
Sept. 1, 2021 | Director | 5,833 | $25.24 | Sell | $147,224.92 | |
Aug. 11, 2021 | Director | 621 | $25.15 | Sell | $15,618.15 | |
Aug. 11, 2021 | CEO | 1,917 | $25.07 | Sell | $48,059.19 | |
Aug. 9, 2021 | Director | 700 | $25.00 | Sell | $17,500.00 | |
Aug. 9, 2021 | CEO | 827 | $25.02 | Sell | $20,691.54 | |
Aug. 6, 2021 | Director | 3,129 | $25.00 | Sell | $78,225.00 | |
Aug. 5, 2021 | CEO | 1,370 | $25.00 | Sell | $34,250.00 | |
June 25, 2021 | Major Shareholder | 7,704 | $29.60 | Sell | $228,038.40 | |
June 23, 2021 | Major Shareholder | 37,980 | $29.80 | Sell | $1,131,804.00 | |
June 21, 2021 | Major Shareholder | 91,620 | $29.70 | Sell | $2,721,114.00 | |
May 7, 2021 | Major Shareholder | 450,000 | $29.98 | Sell | $13,491,000.00 | |
April 14, 2021 | Major Shareholder | 400 | $30.37 | Sell | $12,148.00 | |
Oct. 20, 2020 | Director | 171,875 | $16.00 | Buy | $2,750,000.00 | |
Oct. 20, 2020 | Major Shareholder | 250,000 | $16.00 | Buy | $4,000,000.00 |
Insiders are both buying and selling Tarsus Pharmaceuticals Inc stock.
The insider traders at Tarsus Pharmaceuticals Inc are: Bobak R Azamian, Michael Ackermann, Aziz Mottiwala, Leonard M Greenstein, Vivo Capital Ix, Llc, Bryan Wahl, Jose M Trevejo, Dianne C Whitfield, Seshadri Neervannan, Mark J Holdbrook, Elizabeth Yeu Lin, Bobak R. Azamian, Vivo Capital Fund Ix, L.P., Andrew D Goldberg, Rtw Investments, Lp, and Jason E Tester
The most active insider trader at Tarsus Pharmaceuticals Inc is Bobak R Azamian with 40 trades.
Rtw Investments, Lp has sold the most Tarsus Pharmaceuticals Inc stock with a total value of $26,982,000.00.
Vivo Capital Fund Ix, L.P. has bought the most Tarsus Pharmaceuticals Inc stock with a total value of $8,000,000.00.
The most recent insider trade for Tarsus Pharmaceuticals Inc was on March 18, 2024.
The single biggest insider buy for Tarsus Pharmaceuticals Inc was from Vivo Capital Fund Ix, L.P. with a total value of $4,000,000.00 on Oct. 20, 2020.
The single biggest insider sell for Tarsus Pharmaceuticals Inc was from Rtw Investments, Lp with a total value of $13,491,000.00 on May 7, 2021.